HEALTH CARE UTILIZATION AND COSTS

PUBLICATIONS

Gupte-Singh K, Singh R, Lawson KA, “Economic Burden of Attention Deficit/Hyperactivity Disorder among Pediatric Patients in the United States,” Value in Health, 2017, 20:  602-609.

Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, and Malone DC, “Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost Sharing in Beneficiaries on Dialysis,” Journal of Managed Care and Specialty Pharmacy, October 2015; 21(10):  956-964.

Desai PR*, Lawson KA, Barner JC, and Rascati KL, “Estimating the Direct and Indirect Costs for Community-Dwelling Patients with Schizophrenia,” Journal of Pharmaceutical Health Services Research, published on-line July 16, 2013, doi: 10.1111/jphs.12027; December 2013; 4(4):  187-194.

Nemlekar P*, Shepherd M, Lawson K, and Rush S, “Web-Based Survey to Assess the Perceptions of Managed Care Organization Representatives on Use of Copay Subsidy Coupons for Prescription Drugs,” Journal of Managed Care Pharmacy, October 2013; 19(8):  602-608.

Desai PR*, Lawson KA, Barner JC, and Rascati KL, “Identifying Patient Characteristics Associated with High Schizophrenia-related Direct Medical Costs in Community-Dwelling Patients,Journal of Managed Care Pharmacy, July-August 2013; 19(6):  468-477.

Oramasionwu CU*, Morse GD, Lawson KA, Brown CM, Koeller JM, and Frei CR, “Hospitalizations for Cardiovascular Disease in African-Americans and Whites with HIV/AIDS,” Population Health Management, June 2013; 16(3):  201-207.

 Dasgupta A* and Lawson KA, “Utilization of and Expenditures for Selective Serotonin Reuptake Inhibitors (SSRIs) and Factors Associated with Change in Price Per-Prescription of Brand SSRIs in the Texas Medicaid Program (1991-2009),” Journal of Pharmaceutical Health Services Research, June 2013; 4(2):  105-113.

Lawson KA, Johnsrud MT, Hodgkins P, Sasane R, and Crismon ML, “Utilization Patterns of Stimulants in ADHD in the Medicaid Population:  A Retrospective Analysis of Data from the Texas Medicaid Program,” Clinical Therapeutics, April 2012; 34(4):  944-956.

Shcherbakova N*, Shepherd M, Lawson K, and Richards K, “The Role of Authorized Generics in the Prescription Drug Marketplace,” Journal of Generic Medicines, January 2011; 8(1):  28-40, (DOI:  10.1057/jgm.2011.6). [Most Read Articles during August 2011]


PRESENTATIONS

Park C, Lawson KA, Barner JC, Powers DA, Rascati KL, Wilson JP, “Comorbidity Measures to Predict Healthcare Costs among Elderly Gynecologic Cancer Survivors in the U.S.:  An Analysis of SEER-Medicare Data,” International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 22nd  Annual International Meeting, Boston, MA, May 20-24, 2017 (published abstract PCN92, Value in Health, May 2017; 20(5):  A103).

Desai P*, Lawson KA, Richards KM, Rascati KL, Barner JC, Miller A, “Assessing Factors Associated with Antipsychotic Polypharmacy in the Texas Medicaid Population,” International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting, Washington, DC, May 22-25, 2016 (published abstract PMH80, Value in Health, May 2016; 19(3):  A196).

Ma X*, Park C*, Lawson KA, “Arthritis-Related Medical Care Utilization and Expenditures under Gatekeeper and Non-Gatekeeper Plans using Medical Expenditure Panel Survey (MEPS) Data,” International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting, Washington, DC, May 22-25, 2016 (published abstract PHS109, Value in Health, May 2016; 19(3):  A28-A29).

Kang HA*, Makhinova T*, Ogunsanya M*, Lawson KA, “Economic Burden Attributable to Obesity in Adult Patients with Rheumatoid Arthritis in the United States,” International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting, Washington, DC, May 22-25, 2016 (published abstract PHS113, Value in Health, May 2016; 19(3):  A29).

Singh RR*, Lawson KA, Barner JC, Richards KM, Sasane R, Wilson JP, “Time-to-Initiation, Healthcare Utilization, and Costs of Treatment of Attention Deficit Hyperactivity Disorder among Texas Medicaid Preschoolers,” International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting, Washington, DC, May 22-25, 2016 (published abstract PMH34, Value in Health, May 2016; 19(3):  A187-A188).

Richards KM, Lawson KA, Nazareth T, Zhou H, Burton E, Yu T-C, Sasane R, “Disease-Modifying Therapy Utilization among Medicaid Patients with Multiple Sclerosis,” Consortium of Multiple Sclerosis Centers 2015 Annual Meeting, Indianapolis, IN, May 27-30, 2015.

Park C*, Lawson KA, “Estimation of Direct Healthcare Costs of Gynecologic Cancer in the U.S.:  An Analysis of 2007-2011 Medical Expenditure Panel Survey (MEPS) Data,” International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual International Meeting, Philadelphia, PA, May 16-20, 2015 (published abstract PCN49, Value in Health, May 2015; 18(3):  A198).

Ma X*, Lawson KA, Richards KM, “Prescribing Patterns and Expenditures for Otitis Media-Related Antibiotics for Children in the Texas Medicaid Program,” International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 6th Asia-Pacific Conference, Beijing, China, September 6-9, 2014.

Singh RR*, Lawson KA, “Healthcare Associated Infections:  Estimating the Direct Medical Cost, Length of Stay, and Impact of Reimbursement Change on Health Care Associated Infections,” International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 17th Annual European Congress, Amsterdam, The Netherlands, November 8-12, 2014 (abstract PIN118 published in Value in Health, 2014; 17(7):  A684).

Desai P* and Lawson KA, “Comparison of Healthcare Utilization and Costs Associated with Attention Deficit Hyperactivity Disorder (ADHD) Patients Initiated on Different Stimulants,” American Pharmacists Association Annual Meeting and Exposition, Orlando, FL, March 28, 2014. (Platform)

 



Facebook link iconMake a Gift
Texas Pharmacy: The University of Texas at Austin College of Pharmacy